← Back to catalogue

Mi-Axus Catheter

FDA UDI

Class II (US FDA UDI)

by Mivi Neurovascular

Identity

Trade Name
Mi-Axus Catheter FDA UDI
Generic Name
Vascular guide-catheter, single-use FDA UDI
Device Name
The Mi-Axus 6F Distal Access Catheter is a single lumen, braided shaft, variable stiffness catheter with radiopaque marker on the distal end and a luer hub on the proximal end. The catheter shaft has a hydrophilic coating on the last 60 cm of the distal end. FDA UDI
Model / Reference
MIA-57112 FDA UDI
Description
The Mi-Axus 6F Distal Access Catheter is a single lumen, braided shaft, variable stiffness catheter with radiopaque marker on the distal end and a luer hub on the proximal end. The catheter shaft has a hydrophilic coating on the last 60 cm of the distal end. FDA UDI

Identifiers

Primary DI / UDI-DI
B293MIA571120 FDA UDI
510(k) Number
K140557 FDA UDI
FDA Product Code
DQY FDA UDI
GMDN Term
Vascular guide-catheter, single-use FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
870.1250 FDA UDI
Commercial Distribution
Not in Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Dimensions & Sizes

Size
Catheter Gauge — 6 French FDA UDI
Length — 112 Centimeter FDA UDI

Mi-Axus Catheter by Mivi Neurovascular — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Mivi Neurovascular

Sources (1)

  • FDA UDI 49ef7264-69b2-4114-a18a-1939dd80f683 37 fields · synced Jun 8, 2026